Research ArticleCancer

PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity

See allHide authors and affiliations

Science Translational Medicine  08 Jul 2020:
Vol. 12, Issue 551, eaaz5683
DOI: 10.1126/scitranslmed.aaz5683

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article